Global Disposable Endoscopes Market

Disposable Endoscopes Market Size, Share, Growth Analysis, By Application(Bronchoscopy, ENT Endoscopy), By End Use(Hospitals, clinics) - Industry Forecast 2024-2031

Report ID: SQSG35A2041 | Region: Global | Published Date: April, 2024
Pages: 275 | Tables: 61 | Figures: 75

Disposable Endoscopes Market Insights

Disposable Endoscopes Market size was valued at USD 1.7 billion in 2019 and is poised to grow from USD 1.99 billion in 2023 to USD 6.15 billion by 2031, growing at a CAGR of 17% in the forecast period (2024-2031).

One of the key elements expected to fuel market growth is the expanding cross-contamination problem with reusable endoscopes. In 2021, one in every twenty patients will have a pathogen contamination concern, according to Mr. Brian Dunkin, MD, CMO of Boston Scientific Endoscopy. Additionally, it is expected that the adoption of disposable endoscopes would rise as a result of numerous laborious sterilisation procedures to get rid of all kinds of pathogens from the reusable endoscopes.

For instance, cleaning endoscopes during ERCP operations, according to Boston Scientific, necessitates over 100 manual processes and is prone to error. The market is expanding as a result of the rising preference of medical professionals for single-use or disposable endoscopic devices. For single-use endoscopes, The Centers for Medicare & Medicaid Services (CMS) 2021 has introduced a new device passcode. This code is used by hospitals and ambulatory surgical centres (ASCs) in the United States to bill Medicare for the use of single-use duodenoscopes.

The COVID-19 epidemic had a moderately negative impact on the growth of the disposable endoscope market. Adoption of the product was additionally impeded by the COVID-19 pandemic's reduction in surgical procedures. Additionally, the COVID-19 pandemic increased the usage of single-use devices because of the paucity of medical personnel brought on by the elevated infection risks connected with cleaning endoscopes. For instance, a study published in the Journal of Bronchology & Interventional Pulmonology in 2019 found that roughly 20% of health workers in Italy and 11% of health workers in the United States both had COVID-19.

However, because of its safety and the removal of infection risks, COVID-19 is predicted to gradually disappear, increasing the market for single-use endoscopes. Additionally, single-use gadgets are more economical than reusable ones, which is expected to fuel market expansion. For instance, the average cost per patient for reusable flexible bronchoscopes is £511.00 with an associated infection risk of 2.8%, according to statistics from the Association of Anesthetics published in November 2021. Single-use flexible bronchoscopes are predicted to cost on average £220.00 per patient and carry a 0% infection risk.

Similar to this, a 2021 study in the Chest Journal found that hospitals spend between 21 and 155% more per instrument on reusable bronchoscopes than on disposable endoscopes. Cost-effectiveness, reduced risk of cross-contamination, and less resource use are thus expected to fuel market expansion throughout the ensuing years. It is projected that the market will continue to grow as a result of the quick development of technology and the increasing investments made by major manufacturers in the creation of new, creative products. For instance, the single-use endoscope manufacturer Ambu A/S introduced the Ambu aView 2 Advance display for endoscopes in May 2021.

US Disposable Endoscopes Market is poised to grow at a sustainable CAGR for the next forecast year.

Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.



Disposable Endoscopes Market size was valued at USD 1.7 billion in 2019 and is poised to grow from USD 1.99 billion in 2023 to USD 6.15 billion by 2031, growing at a CAGR of 17% in the forecast period (2024-2031).

To expand their product range and maintain a dominant position in the market, major manufacturers are concentrating on implementing critical business strategies like collaboration, acquisition, and new product releases. Ambu debuted its three brand-new disposable endoscopes in 2021: the gastroscope, duodenoscope, and colonoscope. Zsquare, an Israeli endoscopy company, got US$ 10 million in February 2021 for the creation of a single-use endoscopic platform multiplier. 'Ambu A/S', 'Boston Scientific Corporation', 'CONMED Corporation', 'Cook Medical Incorporated', 'EndoChoice Holdings, Inc.', 'Fujifilm Holdings Corporation', 'Hoya Corporation (Pentax Medical)', 'Johnson & Johnson', 'KARL STORZ GmbH & Co. KG', 'Medtronic plc', 'Olympus Corporation', 'Richard Wolf GmbH', 'Smith & Nephew plc', 'Stryker Corporation', 'Teleflex Incorporated', 'XION GmbH', 'CooperSurgical, Inc. (Wallach Surgical Devices)', 'Micro-Tech Endoscopy', 'Welch Allyn, Inc. (Hill-Rom Holdings, Inc.)', 'Zhejiang Tiansong Medical Instrument Co., Ltd.'

More advancements in this field will be driven by combining and merging various imaging and visualisation techniques like computed tomography and magnetic resonance imaging with endoscopic images, connecting and integrating medical devices in the operating room, and combining endoscopic visualisation with tools, lasers, and other devices and technologies. As a result, during the expected period, technological developments will drive the market for disposable endoscopes to rise.

market expansion is aided by rising consumer demand for low-cost endoscopic operations, an increase in US Food and Drug Administration approvals, and more favourable government rules governing disposable endoscopes. The rise in healthcare spending, increased public awareness of diseases brought on by tainted reusable endoscopes, and an increase in the prevalence of acquired infections linked to medical care are further factors driving the disposable endoscopes market. Medical waste is produced by disposable endoscopes, endangering the environment. Because of this, skilled healthcare professionals no longer favour disposable endoscopes, which inhibits the market's expansion. The market is further constrained by the developing world's low disposable endoscope adoption rates.

With a sales share of more than 41.5% in 2021, North America dominated the market. It is due to the widespread use of cutting-edge technologies, the presence of sophisticated infrastructure, and rising public knowledge of surgeries that require the least amount of incision possible. The regional market is also expected to be driven by the rising incidence of gastrointestinal illnesses, cancer, and the ageing population. Data from the National Cancer Institute show that in 2021, there were around 1,806,590 new cancer cases diagnosed in the United States. In addition, the Centers for Disease Control and Prevention (CDC) reports that approximately 2.4 million Americans saw doctors for digestive system problems.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.


Feedback From Our Clients

Global Disposable Endoscopes Market

Product ID: SQSG35A2041